Soft palate cancer
Soft palate cancer accounts for 13.5% of primary palate malignant tumors. Its etiology is similar to that of other malignant tumors in the oropharynx. The most common pathological type is glandular epithelium, followed by squamous epithelium, malignant melanoma ranks third, and sarcoma is rare.
-
Site of disease:
mouth -
Infectious :
Not contagious -
Frequent population:
Middle-aged and elderly people -
Related symptoms:
Soft palate pain dysphagia temporal pain asymmetric soft palate movement dysphagia -
Concurrent disease:
Related Drugs
Pingyangmycin Hydrochloride for Injection
Indication: It is mainly used to treat lip cancer, tongue cancer, gum cancer, nasopharyngeal cancer and other cervical squamous cell carcinomas.
Manufacturer:
Han Hui Pharmaceuticals Company Limited
Related Ingredients